Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms

Bibliographic Details
Main Authors:	Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, Jinbing Zhu, Ailin Zhao, Mingsong Shi, Xue Yuan, Minghai Tang, Jianhong Yang, Heying Pei, Zhuang Yang, Qiang Chen, Haoyu Ye, Ting Niu, Lijuan Chen
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-06-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-024-01058-y

Internet